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Health related quality of life two to five
years after gestational diabetes mellitus:
cross-sectional comparative study in the
ATLANTIC DIP cohort
Andriy Danyliv1,2*, Paddy Gillespie1, Ciaran O’Neill1, Eoin Noctor2, Angela O’Dea2,5, Marie Tierney2,5,
Brian E. McGuire3,5, Liam G Glynn4 and Fidelma P Dunne2,5
Abstract
Background: There is no consensus on the effect of gestational diabetes mellitus (GDM) on health-related quality
of life (HRQOL) for the mother in the short or long term. In this study we examined HRQOL in a group of women
who had GDM in the index pregnancy 2 to 5 years previously and compared it to a group of women with normal
glucose tolerance (NGT) in the index pregnancy during the same time period.
Methods: The sample included 234 women who met International Association of Diabetes Study Groups (IADPSG)
criteria for GDM in the index pregnancy and 108 who had NGT. The sample was drawn from the ATLATIC-DIP
(Diabetes In Pregnancy) cohort – a network of antenatal centers along the Irish Atlantic seaboard serving a
population of approximately 500,000 people. HRQOL was measured using the visual analogue component of the
EQ-5D-3 L instrument in a cross-sectional survey.
Results: The difference in HRQOL between GDM and NGT groups was not significant when adjusted for the effects
of the covariates. HRQOL was negatively affected by increased BMI and abnormal glucose tolerance post-partum in
the NGT group. Moderate alcohol consumption was positively associated with HRQOL in the NGT group only. The
negative association with smoking on HRQOL was substantially higher in the GDM group.
Conclusions: A diagnosis of GDM does not appear to have an adverse effect on HRQOL, 2 to 5 years after the
index pregnancy. On the contrary, its diagnosis might lead to the development of coping strategies, which,
consequently attenuates the adverse effect of the subsequent acquisition of abnormal glucose tolerance post-
partum on HRQOL. Women whose pregnancy was affected by GDM are more susceptible to the adverse effects on
HRQOL of alcohol use and tobacco smoking.
Keywords: Gestational diabetes mellitus, Health related quality of life, Post-partum, Health outcomes
Background
Gestational diabetes mellitus (GDM) is defined as any
degree of glucose intolerance with onset or first recogni-
tion during pregnancy and is associated with several ma-
ternal and neonatal complications [1]. Estimates of the
prevalence of GDM vary across countries and ethnic
groups, in part due to differences in diagnostic criteria
[2]. However, there is a broad recognition that the preva-
lence is increasing primarily due to rising obesity levels
[1, 3]. In the Irish population, GDM was estimated to
affect 12.4 % of the pregnancies when universal screen-
ing and IADPSG criteria were used [4].
There is a large body of evidence showing the adverse
consequences of GDM in the index pregnancy for both
the mother and her offspring [4–6]. As a result, strat-
egies to effectively screen and treat GDM have been im-
plemented in many countries. A number of studies have
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shown that these strategies are associated with a reduc-
tion in perinatal complications [7, 8]. The National Insti-
tute for Health and Care Excellence (NICE) in the
United Kingdom recognizes these strategies as being po-
tentially cost-effective, though internationally evidence
on their effectiveness is lacking [9].
For the purpose of resource allocation, a generic meas-
ure of effect, i.e. health-related quality of life (HRQOL), is
of particular interest as it captures a more complex set of
outcomes beyond clinical effects. Despite the growing
body of knowledge on the detrimental clinical effects of
GDM for mothers and infants, there is no consensus
about its impact on HRQOL. A number of studies demon-
strate that GDM is not associated with a reduced HRQOL
[10, 11], lower perceived health status [12], or mood pro-
file [13, 14], and does not cause depression or anxiety [11,
15]. By contrast, other studies demonstrate that GDM ad-
versely affects HRQOL [16], perceived health status [17]
and causes depression during pregnancy [18, 19] or after
pregnancy [17]. In the long term, Feig et al., [20] reported
that women affected by GDM in Canada report lower
HRQOL (SF-36) 2 to 5 years after delivery. The authors
[20] attribute this to the ‘labeling effect’ of the diagnosis
rather than to real health consequences of GDM.
In this study, we add to the current literature by exam-
ining HRQOL 2 to 5 years post pregnancy in a sample
of women who were part of the ATLANTIC-DIP (Dia-
betes in Pregnancy) cohort. This time frame allows for
the capture of the long term effects of GDM [20]. Not-
ably, the sample included two categories of women: (i)
those diagnosed with GDM on IADPSG criteria following
universal screening and (ii) those with normal glucose tol-
erance (NGT). In our analysis, we compared self-reported
HRQOL, measured using the visual analogue scale (VAS)
component of the EQ-5D-3 L in the two groups. Further-
more, we explored the patient characteristics (outlined in
Appendix 1) that might also influence self-reported
HRQOL in both patient cohorts.
Methods
Data
The study is based on the data collected within the frame-
work of the ATLANTIC-DIP collaborative which has been
described previously [4]. In brief, ATLANTIC-DIP is a net-
work of antenatal centers along the Irish Atlantic seaboard
serving a population of approximately 500,000 people. This
regional area can be considered as broadly representative
of the whole population of Ireland [21]. Pregnant women
were offered screening at 24–28 weeks’ gestation using a
75-g oral glucose tolerance test (OGTT) with fasting, 1-h,
and 2-h values. In total, 5,500 completed the screening.
Henceforth, we refer to the pregnancy in this period as an
index pregnancy. Of those screened, 12.4 % had GDM by
IADPSG criteria [4].
In a subsequent follow-up study [22], 270 women with
GDM (GDM group) and 388 women with NGT (NGT
group) in the index pregnancy returned for a follow-up
screen using a 75-g OGTT 2 to 5 years after the index
pregnancy. In the current study, we build on this follow-
up study by administering a postal questionnaire (in
March 2013) to all of these women. This questionnaire
contained questions on HRQOL assessed via the EQ-
5D-3 L (with VAS component), healthcare service use,
and socio-economic characteristics. The VAS compo-
nent valued the HRQOL on a scale anchored from 0
(the worst health one can imagine) to 100 (the best
health one can imagine). In total, 342 women responded
to the questionnaire (52 % of the original sample) and
were included in the analysis: 231 of these women had
NGT and 111 had GDM in the index pregnancy. The
participants of the study gave informed consent in writ-
ing at every stage of the study, i.e. initial and follow-up
screening, and follow-up survey. The study was ap-
proved by the Irish Health Service Executive Clinical Re-
search Ethics Committee (reference C.A.537).
Outcomes
HRQOL was assessed via patient responses to EQ-5D-
3 L. This is a multi-attribute instrument to measure
HRQOL based on five health dimensions: mobility, self-
care, usual activities, pain and discomfort, and anxiety
and depression [23]. It also contains an instrument for a
direct measurement of the self-reported HRQOL via
VAS. In this study, we focus on the self-reported
HRQOL via VAS only. The multi-attribute generic in-
strument EQ-5D-3 L produced highly homogenous re-
sults which in general exceeded the self-reported status
(see Additional file 1). Hence, we found this generic in-
strument to be insensitive for detecting HRQOL differ-
ences in women affected by GDM.
Analysis showed that the HRQOL measurement had a
skewed distribution which could not be corrected by
logarithmic transformation. Therefore, the utility decre-
ment (henceforth UD), representing the distance to per-
fect health was applied. The UD is measured as:
UD ¼ 100−HRQOL ð1Þ
The distribution of UD was still found to significantly
differ from the normal based on a Shapiro-Wilk test, as
was the HRQOL. However, its properties (unbounded
on logarithmic scale) preconditioned its use for further
analysis in the regression models.
Covariates
For the multivariate analysis, a set of covariates were
chosen to investigate the impact of a diagnosis of GDM
on HRQOL. Selection of covariates was based in part on
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previous studies [10] and in part on that which was
available in the dataset. The detailed definition of the
variables may be found in Additional file 2. Briefly, the
main groups of factors were the indication of acquired
abnormal glucose tolerance after the pregnancy, age, life-
style indicators (BMI, fruit and vegetable intake, exercising
30 min a day), risky behavior in terms of alcohol and to-
bacco use, mode of delivery in the index pregnancy, subse-
quent miscarriages, and a set of socio-economic indicators
(income, employment and cohabiting status). The two in-
dicators, possession of a ‘medical card’ and private health
insurance, were introduced in the analysis as they might
have impacted on health service utilization, and conse-
quently on HRQOL, and may represent socio-economic
status as well [24, 25]. In Ireland, a medical card is issued
based on low income, age, or financial hardship as a result
of a medical condition and entitles the holder to free
health care. Private health insurance, depending on the
level chosen, can cover some health care costs and is usu-
ally purchased by people with high income. We also con-
trolled for the time elapsed after the index delivery before
the HRQOL measurement.
Statistical analysis
A series of univariate analyses were undertaken to exam-
ine if the samples differed by the characteristics men-
tioned above. This consisted of independent two-tailed
t-tests for continuous variables, and χ2 tests for categor-
ical variables. For the multivariate analyses, the choice of
estimation approach was informed by the nature of the
dependent variable, i.e. utility decrement. Specifically, a
generalized linear model with log link and Gaussian
family of the error term distribution was selected (the
distribution of the utility decrement is intrinsically con-
tinuous and, therefore, Gaussian family was preferred, al-
though Modified Park’s test favored Poisson’s distribution).
The coefficients in the model represent the effect on the
utility decrement on the logarithmic scale and, therefore,
have opposite effect on the HRQOL, i.e. positive coeffi-
cients mean reduction in HRQOL and negative – increase
in HRQOL.
The women in our study were selected from a number
of antenatal study centers. In order to detect explicitly if
there were differences between the study centers, we ap-
plied center-specific constant effects. Statistical signifi-
cance was explored at three levels (0.05, 0.01, and 0.001).
All analyses were performed using STATA 12 software.
Results
Summary statistics
The descriptive statistics for the sample are presented in
Table 1. The two groups appear to be different in many
of the presented characteristics. Most importantly, the
group of GDM women tended to have slightly lower
HRQOL than the group with NGT, i.e. 80.31 vs 83.98.
As expected, GDM women appeared worse off in terms
of health outcomes and health related behavior, i.e. they
more frequently acquired abnormal glucose tolerance post-
partum, were more prone to be overweight or obese, to
have a caesarian section delivery. There was some imbal-
ance between the groups in terms of distribution across
study centers, but in the multivariate analysis, study center
effect was controlled for. Notably, GDM women were less
likely to consume alcohol, though this difference was at the
verge of significance. In our case, alcohol consumption rep-
resents moderate alcohol consumption as high consump-
tion (14–18 units per week) was reported only in 3 cases.
A potential problem is the small numbers in subgroups
of some variables (acquired abnormal glucose tolerance,
regular fruit and vegetable consumption). Another poten-
tial problem is subgroups with missing values for income
and subsequent miscarriages. Full case analysis (excluding
cases with missing value in at least one of the covariates)
might cause loss of information. Therefore, the full case
multivariate models of the utility decrement were com-
pared to the models where missing values were included
as a separate category. As the results did not differ sub-
stantially between the two specifications, we present the
full case analysis below.
HRQOL patterns
The results of the multivariate analysis of the utility dec-
rement for the GDM and the NGT groups, and the
pooled estimates are presented in Table 2. In general,
the models fit well. The center-specific effects are not
significant and their exclusion improves model fit, which
tells us that there is no heterogeneity of HRQOL across
the study centers (no evidence of selection bias by the
study center). Despite the statistically significant differ-
ence between mean observed self-reported HRQOL in
GDM and NGT groups (unpaired t-test), the results of
the pooled multivariate analysis (accounting for other
covariates) demonstrate that GDM per se does not have
a long term effect on HRQOL. There are, however, dif-
ferences in the effect of other covariates between GDM
and NGT groups.
The coefficients of the income effect have signs con-
sistent with intuition in the NGT group, i.e. higher in-
come is associated with higher HRQOL (lower utility
decrement in the model). The HRQOL in the GDM
group appears not to be affected by any indicators of
socio-economic status, while income and employment
status are significant factors in the NGT group.
A similar pattern is observed for BMI and develop-
ment of abnormal glucose tolerance post-partum. Post
pregnancy abnormal glucose tolerance is associated with
a significant reduction in HRQOL in the NGT group. In
the GDM group, this effect is not significant. In the
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Table 1 Descriptive statistics of the study sample
NGT GDM p-value
N Statistics N Statistics
Total sample size 231 111
HRQOL(VAS), score 0-100 mean (std.err.) 231 83.98 (0.79) 111 80.31 (1.36) 0.020
Age, years mean (std.err.) 231 38.99 (0.31) 111 38.15 (0.44) 0.120
Alcohol cons., units/week mean (std.err.) 231 2.39 (0.20) 107 1.97 (0.28) 0.232
Income (midpoint), € mean (std.err.) 202 36,139 (1044) 91 37,198 (1584) 0.577
Abnormal glucose tolerance post-partum
no % 224 97.0 % 92 82.9 % <0.001
yes % 7 3.0 % 19 17.1 %
Time after delivery
year 2 % 5 2.2 % 32 28.8 % <0.001
year 3 % 20 8.7 % 23 20.7 %
year 4 % 103 44.6 % 33 29.7 %
year 5 % 103 44.6 % 23 20.7 %
Alcohol consumption
no % 78 33.8 % 47 43.9 % 0.072
yes % 153 66.2 % 60 56.1 %
missing % 0 4
Smoking status
past % 70 30.3 % 43 38.7 % 0.283
current % 30 13.0 % 14 12.6 %
never % 131 56.7 % 54 48.6 %
BMI (3 classes)
normal or underweight % 120 51.9 % 35 31.8 % <0.001
overweight % 80 34.6 % 42 38.2 %
obese % 31 13.4 % 33 30.0 %
missing % 0 1
Subsequent miscarriages
no % 196 90.7 % 97 88.2 % 0.469
yes % 20 9.3 % 13 11.8 %
missing % 15 1
Mode of delivery
spontaneous vaginal % 142 63.1 % 47 42.3 % <0.001
caesarian section % 52 23.1 % 52 46.8 %
assisted vaginal % 31 13.8 % 12 10.8 %
missing % 6 0
Cohabiting status
single % 20 8.7 % 11 9.9 % 0.715
cohabiting % 210 91.3 % 100 90.1 %
missing % 1 0
Employment status
not employed % 84 36.7 % 39 35.1 % 0.781
employed or self-empl. % 145 63.3 % 72 64.9 %
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NGT group, HRQOL is lower for those in the over-
weight group (BMI 25–30) and even lower for those
classified as obese (BMI ≥ 30), while in the GDM group,
their HRQOL is not statistically different from that of
women with normal or reduced body mass (BMI <25).
Alcohol and tobacco use appears to have more adverse
effects in the GDM group. Moderate alcohol consump-
tion is associated with better HRQOL only in the NGT
group. Smoking (current smoking) is associated with re-
duced HRQOL in both groups, but the effect is much
stronger in the GDM group.
We found no relation between HRQOL and the indi-
cators of social status and health service access, i.e.
cohabiting status, medical card, and private health in-
surance in any of the study groups. Notably, no asso-
ciation was found between HRQOL and age, which
may be explained by homogeneity between groups on
this characteristic (age ranges 24 to 51 with low variation).
Similarly, mode of delivery, subsequent miscarriages, or
lifestyle indicators (fruit and vegetable consumption and
exercising 30 min a day) were not associated with the
HRQOL level.
Discussion
In this study we compared self-reported HRQOL for
GDM and NGT women 2 to 5 years post pregnancy. We
also explored patient characteristics which may influence
self-reported HRQOL in both patient cohorts. Below, we
discuss the main findings of this study and acknowledge
the study limitations.
GDM effect
Our results suggest that GDM or its diagnosis per se does
not a have substantial adverse effect on HRQOL 2 to
5 years after the index pregnancy. Even though women
with GDM tended to have slightly lower reported HRQOL
than those who had NGT (80.3 versus 84.0), this difference
is not statistically significant if other clinical and socio-
Table 1 Descriptive statistics of the study sample (Continued)
missing % 2 0
Household income level (€)
<10,000 % 10 5.0 % 1 1.1 % 0.184
10,0000-19,999 % 20 9.9 % 15 16.5 %
20,000-29,999 % 45 22.3 % 17 18.7 %
30,000-39,999 % 35 17.3 % 15 16.5 %
40,0000-49,0000 % 46 22.8 % 16 17.6 %
50,000+ % 46 22.8 % 27 29.7 %
missing % 29 20
Medical card
no % 145 63.3 % 69 62.2 % 0.836
yes % 84 36.7 % 42 37.8 %
missing % 2 0
Private health insurance
no % 88 39.1 % 49 44.1 % 0.377
yes % 137 60.9 % 62 55.9 %
missing % 6 0
Daily fruit and veg. intake
no % 5 2.2 % 6 5.4 % 0.112
yes % 226 97.8 % 105 94.6 %
Exercise 30 min a day
no % 34 14.7 % 10 9.0 % 0.140
yes % 197 85.3 % 101 91.0 %
Study center
Site A % 130 56.3 % 40 36.0 % <0.001
Site B % 40 17.3 % 9 8.1 %
Site C % 38 16.5 % 32 28.8 %
Site D % 23 10.0 % 30 27.0 %
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Table 2 Results of the GLM regression of the utility decrement (log link, Gaussian family)
Pooled NGT GDM
coeff. (std.err) coeff. (std.err) coeff. (std.err)
GDM Yes (positive) 0.047
(0.105)
Abnormal glucose tolerance Yes (positive) 0.251 0.566* 0.125
(0.152) (0.254) (0.247)
Time after delivery 2 years = ref.
3 years 0.461* −0.238 0.475
(0.180) (0.335) (0.258)
4 years 0.182 −0.603* 0.200
(0.167) (0.280) (0.244)
5 years 0.063 −0.565* 0.088
(0.171) (0.277) (0.248)
Alcohol consumption Yes −0.279** −0.292* −0.294
(0.095) (0.135) (0.198)
Smoking status Past smoker 0.078 0.048 0.440*
(0.112) (0.159) (0.255)
Current smoker 0.504*** 0.415** 0.823**
(0.125) (0.160) (0.261)
Never sm. = ref.
BMI classification Norm./Underweight = ref.
Overweight 0.159 0.259* 0.168
(0.115) (0.130) (0.238)
Obese 0.436*** 0.513** 0.341
(0.130) (0.177) (0.238)
Age 0.001 0.013 −0.004
(0.012) (0.014) (0.023)
Had subsequent miscarriages Yes 0.235* −0.015 0.135
(0.128) (0.212) (0.239)
Mode of delivery SVD −0.033 −0.116 −0.008
(0.109) (0.136) (0.223)
CS = ref.
Assisted −0.011 −0.023 −0.261
(0.163) (0.185) (0.401)
Cohabiting status cohabits = 1 0.244 0.535 −0.004
(0.164) (0.301) (0.327)
Employment status employed = 1 0.021 0.312* −0.129
(0.102) (0.146) (0.187)
Income level <20,000 = ref.
20,000-29,999 −0.383* −0.492** −0.132
(0.156) (0.188) (0.386)
30,000-39,999 −0.096 −0.259 0.046
(0.158) (0.170) (0.466)
40,0000-49,0000 −0.292 −0.749*** 0.372
(0.158) (0.199) (0.380)
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economic factors are accounted for. Thus, we are discuss-
ing the independent association of GDM diagnosis with
HRQOL, adjusted for the associations caused by other fac-
tors in the regression. Our results add to the evidence that
GDM does not have an effect on HRQOL [10, 11]. We
consider this to be a counter-argument to the studies sug-
gesting adverse ‘labeling effect’ of a GDM diagnosis on the
wellbeing of a woman [20]. Even if such an effect is present,
it is negligible. It should be borne in mind, however, that
these results are estimated from data collected in a region
where GDM diagnosis leads to an appropriate treatment,
i.e. lifestyle advice, blood glucose self-monitoring, and if re-
quired, insulin. They might not hold for other institutional
and cultural contexts, especially where GDM is not diag-
nosed and/or treated in a similar fashion.
Diabetes and abnormal glucose tolerance
Notably, after a GDM pregnancy, women’s HRQOL ap-
pears not to be affected by acquisition of abnormal glu-
cose tolerance or diabetes post-partum, while in the
group of NGT women it appeared to have a negative ef-
fect. Previous evidence demonstrates that people with
diabetes tend to have lower HRQOL than people with-
out diabetes, but proper management of this condition
eliminates this reduction [13, 26]. Thus, it might be
hypothesized that women affected by GDM are likely to
develop coping strategies or to be offered services in re-
sponse to GDM. That is, they undergo certain treatment
procedures and acquire management skills which enable
them to be better able to manage and control abnormal
glucose tolerance upon its development post pregnancy.
In contrast, women with NGT at pregnancy may be less
well equipped with such strategies upon development of
abnormal glucose tolerance post-partum; hence, their
HRQOL appears reduced after the diagnosis.
Risky behavior
Our results indicate that women whose pregnancy was
affected by GDM are more susceptible to the adverse ef-
fects of risky behavior, alcohol use and tobacco smoking
in particular, 2 to 5 years after the affected delivery. We
draw this conclusion based on the observation that
current smoking status has a much stronger negative ef-
fect on HRQOL in the GDM women, while moderate al-
cohol consumption is favorable for the HRQOL of
women who had NGT in the index pregnancy. The
cross-sectional design of our study does not allow us to
explore the mechanisms of these associations; however,
these findings are consistent with the clinical literature.
Smoking might facilitate progression to Type 2 diabetes
Table 2 Results of the GLM regression of the utility decrement (log link, Gaussian family) (Continued)
50,000+ −0.319 −0.637** 0.087
(0.167) (0.203) (0.400)
Medical card Yes −0.067 −0.098 −0.011
(0.139) (0.171) (0.241)
Private health insurance Yes −0.008 0.003 0.064
(0.125) (0.146) (0.219)
Fruit and veg. consumption Yes −0.157 −0.174 −0.650
(0.261) (0.408) (0.413)
Exercises 30 min a day Yes −0.116 −0.099 −0.229
(0.139) (0.163) (0.323)
Center effect Site A = ref.
Site B 0.153 0.165 0.237
(0.135) (0.177) (0.322)
Site C −0.149 −0.063 −0.415*
(0.140) (0.180) (0.250)
Site D 0.174 −0.078 0.154
(0.131) (0.241) (0.220)
Constant 2.760*** 2.773*** 3.350**
(0.571) (0.740) (1.037)
N 261 175 86
Log-likelihood −1,008.31 −657.09 −329.37
P-value (Log-likelihood test) <0.001 <0.001 0.04
*p < 0.05; **p < 0.01; ***p < 0.001
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mellitus (DM) after GDM [27] and is associated with ex-
cessive negative health outcomes in people with diabetes
due to circulatory and cardiovascular complications [28].
There is no clear link between alcohol consumption and
GDM and its effects. However, in people with diabetes,
which is more likely to develop in women with prior
GDM [29], alcohol use worsens glucose control and
might hasten complications [30]. The exact mechanisms
of alcohol and tobacco use in relation to HRQOL and
its components after GDM might be interrogated in a
more detailed cohort study. Our results suggest in-
creased attention should be given to alcohol and tobacco
consumption after a GDM pregnancy.
Limitations of the study
It should be noted that data collection for this study was
powered to answer the question about transition from
GDM to abnormal glucose tolerance or Type 2 DM rather
than to study heterogeneity of HRQOL in the two groups.
There was a 48 % non-response rate and GDM women
were more likely to be non-respondents (59 %) compared
to NGT women (41 %). Moreover, our estimates of post-
partum abnormal glucose tolerance status are lower than
those in the original sample of the women who had a
follow-up screening, i.e. 3.0 % vs 3.6 % in the NGT group,
and 17.1 % vs 26 % in the GDM group. Thus, there might
be some non-response bias embedded in the current study
as the non-respondents seem to have worse health status.
Some relations should be considered cautiously due to
the small size of the subgroups. Similarly, significant re-
lationships could have been undetected for the same rea-
son. Additionally, small subgroups did not allow for the
inclusion of the interactions between the factors.
Another limitation of this study is the overrepresenta-
tion of the GDM group. In this study, it makes up 1/3 of
the total sample, while GDM happens in about 12 % of
all pregnancies [4]. However, substantial group sizes of
GDM and NGT women allow for studying the HRQOL
heterogeneity separately in these groups.
Finally, we focus on the self-reported HRQOL via vis-
ual analogue scale only as the generic EQ-5D-3 L ap-
peared to be insensitive in our sample. Application of
the diabetes-specific HRQOL tools might yield different
results and better detect the differences in HRQOL at-
tributed to diabetic states.
Conclusions
Our results suggest that GDM diagnosis per se does not
have an adverse effect on HRQOL 2 to 5 years after the
index pregnancy. On the contrary, its diagnosis might
lead to the development of coping strategies, i.e. proper
treatment and monitoring of the glucose level, which
consequently may attenuate the adverse effect of the
post-partum development of abnormal glucose tolerance
on HRQOL. Alcohol use and smoking appear to have
worse effects on HRQOL in women with prior GDM
compared to NGT controls. However, the mechanisms of
these effects are not clear and merit further exploration.
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